Non-Small Cell Lung Cancer - MTAPESTRY 201 20230153

The main objective of the study is to characterize safety and efficacy of 2 dose levels of AMG 193 by investigator, and to evaluate AMG 193 monotherapy efficacy by Blinded Independent Central Review (BICR).

ClinicalTrials.gov Link: https://clinicaltrials.gov/study/NCT06593522?id=20230153&limit=10&sort=@relevance&rank=1

Locations: Hartford Hospital, Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut

Contacts: Krystal Myers: Krystal.Myers@hhchealth.org; Siobhan Reilly: Siobhan.Reilly@hhchealth.org